At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Related Posts
Updated FEP BCBS Policy Expected April 1, 2024
As a part of the Academy’s ongoing dialogue with Blue Cross Blue Shield Association (BCBSA) representatives regarding the recent changes to Federal Employee Program (FEP)…
Signed Budget Deal Reduces Medicare Payment Cuts by Half
On Saturday, March 9, 2024, President Biden signed into law the Consolidated Appropriations Act of 2024 (H.R. 4366). This legislation is the result of a…
Academy Weighs in to Support Oklahoma Legislation
The Academy recently submitted letters of support for two bills pending in the Oklahoma legislature. H.B. 3951 would require hearing screening for children at certain…